Archive | Biotechnology ETFs

Is A Little “Bubble Paranoia” Good For Your ETF Portfolio?

Authors Lu Wang and Joseph Ciolli at Bloomberg described the fear of U.S. stocks falling as “bubble paranoia.” Yet, if fundamental and technical indicators both suggest that U.S. stock assets are extremely overvalued, is the maladjustment with some investors or with the markets themselves? The above-mentioned writers explained that U.S. Federal Reserve members believe asset prices [...] Continue Reading...


Why U.S. Small Company ETFs Are Losing Their Way

There has been a great deal of talk about the housing recovery. Sales of existing homes steadily rose between mid-2011 and mid-2013 on the back of a weak U.S. dollar and an increase in the money supply. Indeed, Federal Reserve monetary policy had stimulated demand for U.S. stocks as well as U.S. real estate. Yet [...] Continue Reading...


Value Versus Momentum: What Should You Buy For Your ETF Portfolio

In a world of high-frequency trading, central bank rate manipulation and cross-border fund flows, fundamental value often gets pushed to the back burner. Without question, U.S. stocks are very expensive — inordinately overpriced. Nevertheless, most will opt to continue placing their faith and their hard-earned dollars in what they know. Can one pursue reasonably priced equities [...] Continue Reading...


ETFs With Low P/S Ratios May Be The Only Bargains Left

The 30 companies that comprise the Dow Jones Industrials collectively failed to increase sales in 2013. Yet the price of the Dow surged more than 25%. And while that price appreciation for the big-time benchmark may be slowing, the Dow still managed to eclipse 17,000 without generating much in the way of actual revenue growth. Sales [...] Continue Reading...


Susceptibility 101: ETFs That Are Exceptionally Far From Respective Trendlines

Are investors cautiously optimistic? Probably. A little bit greedy? Maybe. Yet I would be hard-pressed to describe the current psychology in terms of euphoria. The most apt descriptor is complacency. Keep in mind, geopolitical tensions are rising in the Middle East, Ukraine and off the coastal waters near China. Not surprisingly, gasoline prices have remained stubbornly [...] Continue Reading...


“Old Tech” ETFs Are Better Risk-Reward Prospects Than “New Tech” ETFs

Scores of investors often regard Benjamin Graham as the grandfather of value investing. Even those who shun Graham’s methods of analyzing securities tend to revere quotes attributed to him. For example, on market complacency, “… chief losses to investors come from the purchase of low-quality securities at times of good business conditions.” In this discussion, we [...] Continue Reading...


The Great ETF Rotation Is Accelerating

Back on April 9, I talked about a “Great Rotation” away from momentum plays (e.g., biotech, Internet, small-cap growth, etc.). Where did the smart money go? Demand had been picking up for the least popular asset classes from 2013, including long-dated treasuries, select emerging markets as well as commodities. Five trading weeks have passed since I [...] Continue Reading...


ETF Moves You Can Make Before The Crowd Gets Restless

Nobody can tell you when a 10% stock market pullback is imminent. That has not stopped many from issuing erroneous prognostications over the last 31 months. By the same token, no individual can predict when a correction will morph into a 20% bearish sell-off. Yet Marc Faber (”Dr. Doom”) has routinely served up enormously frightful [...] Continue Reading...


Are Emerging Market Small Cap ETFs Safer Than U.S. Small Cap ETFs?

When U.S. stocks have struggled in 2014, the pattern has had a familiar ring to it. Small-caps have fallen harder than large-caps. Growth-oriented equities have dropped more precipitously than value-oriented equities. Meanwhile, consumer Internet assets have jumped off the proverbial cliff. For those who choose to monitor these sorts of unfriendly patterns, the price of Global [...] Continue Reading...


What You Don’t Know About Relative Strength Shifts In ETFs Can Hurt You

One of the best web sites for identifying trends in the ETF marketplace is ETFscreen.com. And one of the best features at the data aggregation portal is the Relative Strength Factor (RSf) reporting. According to ETF Screen, the Relative Strength Factor (RSf) represents a percentile ranking of fund performance relative to all other funds in the [...] Continue Reading...


Free Sign-Up                     ETF Expert RSS Feed  Follow EtfExpert on Twitter

Receive ETF Expert Daily By Email
Get The Weekly ETF Expert Newsletter

Archives